Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study
✍ Scribed by J. D. DOUKETIS; J. A. JULIAN; C. KEARON; D. R. ANDERSON; M. A. CROWTHER; S. M. BATES; M. BARONE; F. PIOVELLA; A. G. TURPIE; S. MIDDELDORP; P. VAN NGUYEN; P. PRANDONI; P. S. WELLS; M. J. KOVACS; M. R. MACGILLAVRY; L. COSTANTINI; J. S. GINSBERG
- Book ID
- 109148923
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 113 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1538-7933
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a casecontrol study of this risk relationship within a cohort of 40-to 74-year-old women in Uppsala County, Sweden, who participated in mammography screening. Incident cases of breast cancer wer
## BACKGROUND. As part of the hereditary nonpolyposis colon carcinoma (HNPCC) constellation of neoplasia caused by defects in mismatch repair genes, some endometrial carcinomas are known to have a genetic contribution to etiology. However, most endometrial carcinomas occur in postmenopausal women
## Abstract Accumulating epidemiological evidence suggests that sex steroid hormones are positively associated with the development of breast cancer. However, most of these studies were conducted among Caucasian women and few have been carried out in China. To determine whether the associations of
## Abstract We examined the associations between various doses and routes of administration of norethisterone acetate (NETA) in estrogen–progestagen therapy (EPT) and the risk of breast cancer in Finland. All Finnish women with first invasive breast cancer diagnosed between the ages of 50–62 during